Laure Degroote

5PUBLICATIONS
35CO-AUTHORS
Molecular targetsFermentationElectrochemical energy storage and conversionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 18, 2026
GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.

|Feb 16, 2026
Iron deficiency induces maturation-dependent loss of pancreatic β-cells.

Annelore Van Mulders, Lien Willems, Sophie Coenen

|Jan 15, 2026
Transient ER stress cell-autonomously promotes beta cell cycling in mice.

Stephanie Bourgeois, Annelore Van Mulders, Yves Heremans

|Nov 19, 2025
Redosing of anti-CD3 antibodies in NOD mice with new-onset diabetes does not alter the effect of a single treatment course.

Amber Wouters, Pierre Lemaitre, Laure Degroote

|Jul 12, 2025
Verapamil and low-dose anti-mouse thymocyte globulin combination therapy stably reverses recent-onset type 1 diabetes in NOD mice by acting on the beta cell and immune axes.

Laure Degroote, Pieter-Jan Martens, Marijke Viaene

Pageof 1

Frequent Collaborators

4 joint publications

Nico De Leu

4 joint publications

Willem Staels

3 joint publications

Lien Willems

3 joint publications

Yves Heremans